The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
Level | Code | Title | |
---|---|---|---|
1 | B | Blood and blood forming organs | |
2 | B02 | Antihemorrhagics | |
3 | B02A | Antifibrinolytics | |
4 | B02AA | Amino acids | |
5 | B02AA02 | Tranexamic acid |
The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.
Route | Amount |
---|---|
ORAL - Oral | 2 g |
PAREN - Parenteral | 2 g |
Active Ingredient | Description | |
---|---|---|
Tranexamic acid |
Tranexamic acid is an antifibrinolytic that competitively inhibits the activation of plasminogen to plasmin. Tranexamic acid is a competitive inhibitor of plasminogen activation, and at much higher concentrations, a noncompetitive inhibitor of plasmin, i.e., actions similar to aminocaproic acid. Tranexamic acid is about 10 times more potent in vitro than aminocaproic acid. Tranexamic acid binds more strongly than aminocaproic acid to both the strong and weak receptor sites of the plasminogen molecule in a ratio corresponding to the difference in potency between the compounds. |
Title | Information Source | Document Type | |
---|---|---|---|
AZEPTIL Capsule | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
AZEPTIL Solution for injection | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
CYKLOKAPRON Solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.